Staff Writer

27
Jun

UK MHRA and BSI Statements In Response to Brexit Referendum

Dr. David Lim (Dr. Lim)’s Recommendations to the UK’s Health Authority, Medicines and Healthcare products Regulatory Agency (MHRA) and the BSI To the UK’s MHRA The MHRA should establish its own medical device approval/registration system within the principles of the EU’s medical device regulation or recognize other CE-marked devices available in the EU. Develop a process of recognizing other CE-marked devices Develop

Read more

3
Jun

Global Adverse Event Databases

The United States Food and Drug Administration Mandatory Reporting According to Applicable Regulations Drugs and Biologics Drugs – FDA Adverse Event Reporting System (FAERS) Data Files Devices Medical Devices – MAUDE (Manufacturer and User Facility Device Experience) Vaccine Adverse Event Reporting System Australia – Therapeutic Goods Administration Database of Adverse Event Notifications (DAEN) The Therapeutic Goods Administration (TGA) receives adverse event reports associated with

Read more

29
May

Glyphosate in Food and Vaccines May Be Linked to Autism

Glyphosate in Food Be Linked to Vaccines Leading to Autism? The potential connection between autism and vaccines has been disputed for a long time.  In the following video, Dr. Stephanie Seneff, Senior Research Scientist at MIT suggests a potential connection between glyphosate in food and vaccines contributing to autism. [youtube_advanced url=”https://www.youtube.com/watch?v=P3Psn_p9_0s” controls=”no” loop=”yes” rel=”no” modestbranding=”yes”] The United States Centers for Disease

Read more

20
May

Movie for Chasing the Dragon – Opioid Addiction

Opioid Addiction Chasing the Dragon: The Life of an Opiate Addict The following movie is for awareness purposes regarding Opioid Addiction in the US.  In the US, it has been a growing epidemic of prescription drug and heroin abuse. The US FBI and DEA have released a movie entitled “Chasing the Dragon: The Life of an Opiate Addict“, a documentary

Read more

11
May

AHRQ Hospital Survey Report on Patient Safety Culture

Agency for Healthcare Research and Quality (AHRQ) 2016 User Comparative Database Report Many hospitals revealed their interest in comparing their results on patient safety culture to other hospitals using the AHRQ hospital survey on Patient Safety Culture. The AHRQ issues 2016 Hospital Comparative Database Report in 87 pages (downloadable in PDF below). 2016 Hospital Comparative Database Report (“Report”) The latest edition

Read more

26
Apr

21 CFR 820.70 Production and Process Controls

21 CFR PART 820 QUALITY SYSTEM REGULATION Subpart G–Production and Process Controls 820.70 Production and process controls (a) General. Each manufacturer shall develop, conduct, control, and monitor production processes to ensure that a device conforms to its specifications. Where deviations from device specifications could occur as a result of the manufacturing process, the manufacturer shall establish and maintain process control

Read more

22
Apr

FDA Proposes Ban on Electrical Stimulation Devices

Electrical Stimulation Devices (ESDs) ESDs Are Intended to Treat Self-injurious or Aggressive Behavior The United States Food and Drug Administration (FDA) is proposing ban on ESDs because they present an unreasonable and substantial risk to public health that cannot be corrected or eliminated through changes to the labeling. Aversive conditioning devices were on the market prior to passage of the Medical

Read more

21
Apr

Improving Awareness of the Importance of Human Factors

Awareness Is Important FDA recently issued draft guidance entitled “List of Highest Priority Devices for Human Factors Review,” informing medical device manufacturers which device types should have human factors data included in premarket submissions (i.e., for PMA or 510(k)). According to the guidance, it seems that FDA believes these device types have clear potential for serious harm resulting from use error, and that

Read more

19
Apr

FDA Reclassifies Cardiovascular EPPG and PSA Devices into Class II

FDA Final Order for Medical Device Reclassification Reclassification of Cardiovascular Devices External Pacemaker Pulse Generator and Pacing System Analyzers 21 CFR Part 870 FDA issues Final Order, effective as of April 18, 2016, to reclassify external pacemaker pulse generator (EPPG) as well as to create a separate classification regulation for pacing system analyzers (PSAs) devices and reclassify PSA devices into

Read more

12
Apr

FDA Approved First Biosimilar Zarxio filgrastim-sndz

The First FDA-Approved Biosimilar Zarxio filgrastim-sndz March 6, 2015 The U.S. Food and Drug Administration today approved Zarxio (filgrastim-sndz), the first biosimilar product approved in the United States. Biological products are generally derived from a living organism. They can come from many sources, including humans, animals, microorganisms or yeast. A biosimilar product is a biological product that is approved based

Read more